Page 113 - CIBERBBN-2015-eng

Research groups
Most relevant scientific articles
IZQUIERDO-BARBA I., GARCíA-MARTíN J.M., ALVAREZ R., PALMERO A., ESTEBAN J., PéREZ-JORGE C. ET AL. Nanoco- lumnar coatings with selective behavior towards osteo- blast and Staphylococcus aureus proliferation. Acta Bio- materialia. 2015;15:20-28.
MARTíNEZ A., FUENTES-PANIAGUA E., BAEZA A., SáNCHEZ- NIEVES J., CICUENDEZ M., GóMEZ R. ET AL. Mesoporous Sil- ica Nanoparticles Decorated with Carbosilane Dendrons as New Non-viral Oligonucleotide Delivery Carriers. Chem- istry - A European Journal. 2015;21(44):15651-15666.
PARIS J.L., CABANAS M.V., MANZANO M., VALLET-REGI M. Polymer-Grafted Mesoporous Silica Nanoparticles
Highlights
The most important achievements during 2015 in- clude the design, optimization and implantation of 3D scaffolds based on bioceramics for bone tissue regeneration, and the development of nanotechno- logical strategies to design smart drug delivery sys- tems for antitumor therapy and infection treatment (www.valletregigroup.esy.es). During 2015, GIBI group has developed diverse research lines in the frame of different national research projects in- cluding MAT2012-35556, MAT2013-43299-R and CSO2010-11384-E and European project within Research and Innovation Actions of Horizon 2020 program (Mozart 685872). Moreover, GIBI group has participated in different Intramural Projects (Nanoantilathiv, 3d-Timpte and Spring), transla- tional CIBER-ECO project (SMART4NB) and private Domingo Martínez foundation project. GIBI group is member of the Research Institute of “Hospital 12 de Octubre (i+12)” and European Networking for prevention and treatment of osteoporotic frac- tures (www.agening.net). GIBI group has also pub- lished 20 original research articles indexed in JCR, 1 PCT-patent, 4 book chapters, 1 complete book enti-
as Ultrasound-Responsive Drug Carriers. ACS Nano. 2015;9(11):11023-11033.
MARTíNEZ-CARMONA M., BAEZA A., RODRIGUEZ-MILLA M.A., GARCíA-CASTRO J., VALLET-REGI M. Mesoporous silica nan- oparticles grafted with a light-responsive protein shell for highly cytotoxic antitumoral therapy. Journal of Materials Chemistry B. 2015;3(28):5746-5752.
VILLEGAS M.R., BAEZA A., VALLET-REGI M. Hybrid Colla- genase Nanocapsules for Enhanced Nanocarrier Penetra- tion in Tumoral Tissues. ACS Applied Materials and Inter- faces. 2015;7(43):24075-24081.
tled “Nanoceramics in Clinical Use: From Materials to Applications” (2nd Edition) of RSC Nanoscience & Nanotechnology Editorial. In addition, 10 invited conferences in international research forums have also highlighted. GIBI group collaborates with many clinic institutions as Hospital Miguel Servet, Zarago- za, La Paz Hospital, Madrid, Alcalá de Henares Uni- versity Hospital, Jimenez Diaz Foundation, Hospital del Mar Barcelona, University Hospital of Getafe, University Children’s Hospital Niño Jesus, Research Institute of Hospital 12 de Octubre (I+12). Further- more, Prof. María Vallet-Regí has coordinated in the Ramón Areces Foundation, the symposium on “The cancer as a result of aging: potential solutions” cel- ebrated on 3rd of November in Madrid. Moreover, the group has received the award IDEA2 (2015) with “Nanodrone: Nanomedicines directed to Neuroblas- toma” proyect. Finally, Prof. María Vallet-Regí has received the degree of Doctor Honoris Causa by Jaume I University and also she has been selected as a member of Spanish Team of Science 2015 by the Quo Magazine.
Institution: Universidad Complutense de Madrid · Contact: Facultad de Farmacia · Ciudad Universitaria, S/N 28040 Madrid · Tel.: 91 394 18 43 · E.mail: [email protected] · Website: http://www.valletregigroup.esy.es
CIBER-BBN I Annual report 2015 I 113